Security key
21077P108
Context Therapeutics Inc. - Common Stock (CNTX)
CUSIP: 21077P108
Q3 2023 13F Holders as of 30 Sep 2023
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 2,578,656
- Total 13F value
- $3,893,359
- Share change
- +339,490
- SEC-reported price per share
- $1.51
- Number of holders
- 23
- Value change
- +$507,040
- Number of buys
- 10
- Number of sells
- 3
- Shares outstanding
- 91,741,639
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2023
Institutions
23
Top holders
10
CNTX full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q4 2023
Previous quarter: Q2 2023
Context Therapeutics Inc. SEC filings
Context Therapeutics Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 21077P108
Recent filing periods:
Ownership snapshot
Top reported holders of CNTX - Context Therapeutics Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Ally Bridge Group (NY) LLC
Disclosed value leader
Ally Bridge Group (NY) LLC
Comparable rows
15/15
Latest evidence
30 Jun 2023
13F
Lead comparable stake: 0.71%
Showing 1-6 of 15 holder rows.
Quick read
Ally Bridge Group (NY) LLC leads the comparable SEC ownership view at 0.71%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Ally Bridge Group (NY) LLC's linked filing trail.
Comparable ownership
Top 5
Ally Bridge Group (NY) LLC
0.71%
VANGUARD GROUP INC
0.63%
Affinity Asset Advisors, LLC
0.29%
HighTower Advisors, LLC
0.14%
GEODE CAPITAL MANAGEMENT, LLC
0.12%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Ally Bridge Group (NY) LLC |
13F
Company
|
0.71%
|
$1,045,434
653,396 shares
|
— | 30 Jun 2023 |
| VANGUARD GROUP INC |
13F
Company
|
0.63%
|
$919,520
574,700 shares
|
— | 30 Jun 2023 |
| Affinity Asset Advisors, LLC |
13F
Company
|
0.29%
|
$428,118
267,574 shares
|
— | 30 Jun 2023 |
| HighTower Advisors, LLC |
13F
Company
|
0.14%
|
$201,000
125,852 shares
|
— | 30 Jun 2023 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
0.12%
|
$171,574
107,234 shares
|
— | 30 Jun 2023 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
Company
|
0.12%
|
$169,294
105,809 shares
|
— | 30 Jun 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2023
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
23
Shares
2,578,656
Rows available
23
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2023 vs Q2 2023 Across Filers
Q2 2023 holders
22
Q3 2023 holders
23
Holder diff
1
| Investor | Q2 2023 Shares | Q3 2023 Shares | Share Diff | Share Chg % | Q2 2023 value | Q3 2023 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend